Verily Life Sciences, a division of Google parent company Alphabet, has teamed up with French healthcare company Sanofi to launch Onduo, a diabetes-focused collaboration that leverages Sanofi’s pharmaceutical expertise and Verily’s command of miniaturized electronics, analytics and consumer software development. The two companies together invested about $500 million in Onduo.
The joint venture is...
Considering recent events, big name consumer brands are more likely than ever to move into regulated medical devices.
Two weeks ago Apple CEO Tim Cook told a newspaper that while his company wouldn't put the Apple Watch through the motions of an FDA clearance process, Cook "wouldn't mind putting something adjacent to the watch through it." He said that before adding maybe that'd be an app or...
Propeller Health is working with Boehringer Ingelheim.
Pharma's investment in the digital health space is getting more and more real and substantive as companies move beyond the pilot stage and start to launch real digital health interventions, from Teva buying up smart inhaler company Gecko to Otsuka gearing up to launch a commercial drug integrated with a Proteus sensor.
But digital...
Sanofi's IBG Star connected glucometer.
Google Life Science's recently-announced partnership with Dexcom (not to mention its contact lens project with Novartis) have already made it clear that diabetes is a focus for the company. Now the company is making that focus official in a new partnership with Sanofi and the Joslin Diabetes Center.
"Today, we’re announcing a new partnership with Sanofi...
Vancouver-based Ayogo has raised $2.5 million from Merck Global Health Innovation Fund (GHI), Excel Venture Management, and 7Wire Ventures for it's patient engagement offering, an app called Empower.
The app, designed for providers and pharma companies, helps patients with chronic conditions stick to their care plans. Patients can use the app to set their own goals, track their health and...
Austria-based diabetes app company mySugr has raised $4.8 million from Roche Ventures and iSeed Ventures. Existing investor XLHealth also contributed to the round, which will help mySugr scale up its user base in the US and other other countries. iSeed Ventures is a new fund that has only made a half dozen investments so far, and it is led by former iHealth Lab head Adam Lin.
MySugr offers a...
The FDA approved its first fully remote clinical trial in 2012, but that attempt, by Pfizer and Exco InTouch, ended up folding and plans for a mulligan never came to fruition. Now Sanofi is backing another attempt at a fully remote trial, this time in Europe. Scotland-based eClinicalHealth will run the trial, called the VERKKO trial.
"This whole mechanism of doing studies in this manner is being...
Burlingame, California-based Misfit, formerly Misft Wearables, today launched Misfit Flash, its second wearable device that tracks various activities and sleep. The sub-$50 Flash's pricepoint isn't the only difference between it and Misfit's original device, Shine. Flash is made out of "soft-touch" plastic instead of the Shine's stainless steel body. Flash comes in a variety of colors including "...
Sanofi Diabetes, a division of Sanofi-Aventis, has launched a new mobile game for iOS and Android phones in the United Kingdom. The game, called Mission T1D, is meant to be educational, to teach children as well as their parents, caregivers, and friends about Type 1 diabetes.
"Children with diabetes and their families face many challenges in their daily lives as they care for a very complex life-...
Voluntis's app (not shown here) was one of the first to work with Sanofi's IBGStar connected glucometer.
Paris, France-based Voluntis, a developer of companion apps for medical devices, has raised $29 million in its fourth round of funding. The round was led by Bpifrance Large Venture and international venture capital firm Innovation Capital. Other contributors included Luxemburg-based...
.jpeg?itok=HF3iI7dj "Person answering their front door and getting a delivery from another person")
